What are Wall Street's price targets for Orthofix medical's stock?
2 Wall Street analysts have issued 1-year price targets for Orthofix Medical's shares. Their forecasts range from $60.00 to $60.00. On average, they anticipate Orthofix Medical's stock price to reach $60.00 in the next twelve months.
Who owns Orthofix medical (orfX) stock?
Only 4.00% of the stock of Orthofix Medical is held by insiders. 96.19% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
What kind of company is ofix?
The Company is a diversified orthopedic products company, designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. OFIX earnings call for the period ending September 30, 2021. OFIX earnings call for the period ending June 30, 2021.
What does Orthofix medical's P/E ratio mean?
The P/E ratio of Orthofix Medical is -42.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Orthofix Medical is -42.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Is OFIX stock a buy right now?
1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1...
Will Orthofix Medical's stock price go up in 2022?
1 analysts have issued 12-month target prices for Orthofix Medical's stock. Their forecasts range from $45.00 to $45.00. On average, they predict O...
How has Orthofix Medical's stock performed in 2022?
Orthofix Medical's stock was trading at $31.09 on January 1st, 2022. Since then, OFIX shares have decreased by 12.4% and is now trading at $27.24....
When is Orthofix Medical's next earnings date?
Orthofix Medical is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Ortho...
How were Orthofix Medical's earnings last quarter?
Orthofix Medical Inc. (NASDAQ:OFIX) released its earnings results on Friday, May, 6th. The medical device company reported ($0.10) earnings per sha...
What guidance has Orthofix Medical issued on next quarter's earnings?
Orthofix Medical issued an update on its FY 2022 earnings guidance on Monday, June, 6th. The company provided earnings per share (EPS) guidance of...
Who are Orthofix Medical's key executives?
Orthofix Medical's management team includes the following people: Mr. Jon C. Serbousek , Pres, CEO & Director (Age 61, Pay $1.57M) Mr. Douglas C...
What is Brad Mason's approval rating as Orthofix Medical's CEO?
32 employees have rated Orthofix Medical CEO Brad Mason on Glassdoor.com . Brad Mason has an approval rating of 73% among Orthofix Medical's emplo...
Who are some of Orthofix Medical's key competitors?
Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT) , Medtronic (MDT) , Stryker (SYK) , Intuitive Surgical (I...
What is the ticker symbol for Orthofix?
Who bought Orthofix Medical stock?
Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."
What is the P/E ratio of Orthofix Medical?
Company insiders that have bought Orthofix Medical stock in the last two years include James F Hinrichs, Jon Carl Serbousek, and Ronald A Matricaria.
How much does Orthofix make?
The P/E ratio of Orthofix Medical is -41.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What is Orthofix Medical?
Orthofix Medical has a market capitalization of $750.71 million and generates $406.56 million in revenue each year. The medical device company earns $2.52 million in net income (profit) each year or $0.26 on an earnings per share basis.
Is Orthofix a hold stock?
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Is there enough data for Orthofix?
There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Orthofix Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
